Call to improve transparency of trials of non-regulated interventions

Rafael Dal‐Ré; Michael B. Bracken; John P A Ioannidis

doi:10.1136/bmj.h1323

Abstract

1 min read

The public and clinicians require transparent, quality evidence for all interventions. Trials of non-regulated interventions are common, and efforts to improve their registration and publication compared with drug trials are overdue, say <b>Rafael Dal-Ré, Michael Bracken, </b>and<b> John Ioannidis</b>

Related publications

Letter2021

Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines

Hussein Ibrahim, Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, An‐Wen Chan, Matthew R. Sydes, Melanie Calvert, Alastair K. Denniston

Article2014

Registering Diagnostic and Prognostic Trials of Tests: Is It the Right Thing to Do?

Nader Rifai, Patrick M. Bossuyt, John P A Ioannidis, Kurtis R. Bray, Lisa M. McShane, Robert Golub, Lotty Hooft

Preprint2023

Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews

Emmanuel A. Zavalis, Anaïs Rameau, Anirudh Saraswathula, Joachim Vist, Ewoud Schuit, John P A Ioannidis

Article2019

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey

Athina Tatsioni, Fotini B. Karassa, Steven N. Goodman, Deborah A. Zarin, Daniele Fanelli, John P A Ioannidis

Article2024

Reporting randomised trials of social and psychological interventions: The CONSORT-SPI 2018 Extension

David Moher, Steven D. Hollon, Edmund Sonuga‐Barke, Peter Craig, Stavros Konstantopoulos, P. Kaufmann, Larry V. Hedges, A Nezu, B. Mittman, Sally Hopewell, Susan Michie, Anna Booth, Kamaldeep Bhui, Gary R. VandenBos, Frances Gardner, M.W. Fraser, Geraldine Macdonald, Evan Mayo‐Wilson, Sean Grant, Douglas G. Altman, J. Lawrence Aber, Dav Clark, Mark Eisner, James Thomas,